Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Diabetes 68, 2133
Mass-spec identity Identity support packet can be matched to the requested SKU
(15:50) Running into the resistance wall
Swiss Chems Provider Profile Name: Swiss Chems Website: swisschems.com Founded: August 2018 Provider Type: Research Peptide Vendor FDA Warning Letter: December 10, 2024 Operating Details E-commerce peptide vendor Received an FDA warning letter in December 2024 after an investigation found the company was selling semaglutide and retatrutide products for human use despite marketing them for research and chemical purposes No prescription required for purchase Products sold as freeze-dried powders requiring reconstitution About the Company Swiss Chems was among the companies targeted in the FDAs December 2024 enforcement wave, alongside Xcel Peptides, Summit Research, and Prime Peptides, all found to be selling semaglutide, tirzepatide, and/or retatrutide for human use despite marketing the drugs for research and chemical purposes
US$ 26.50
US$ 21.71
US$ 28.80
